Vepdegestrant is an investigational, orally bioavailable PROTAC estrogen receptor degrader. In the VERITAC-2 Phase 3 study, vepdegestrant demonstrated statistically significant and clinically ...

A good way to make your presentations effective, interesting and easy to follow is to use signpost language. 'Signpost language' is the words and phrases that people use to tell the listener what has ...

How to manage the eight critical elements of organizational life by Boris Groysberg, Jeremiah Lee, Jesse Price and J. Yo-Jud Cheng Strategy and culture are among the primary levers at top leaders’ ...

Need a projector for business presentations, fast-paced gaming, or family movie night? We've tested these top-rated portable and full-size projectors to help you find just the right one for home, the ...

Angelo Di Mambro joined Euractiv in January 2024 as editor for EU agriculture and food policies. Based in Brussels since 2011, he authored publications on the global challenges facing agriculture, the ...

Dr. JeFreda R. Brown is a financial consultant, Certified Financial Education Instructor, and researcher who has assisted thousands of clients over a more than two-decade career. She is the CEO of ...

Title: I-SPY2 Endocrine Optimization Pilot (EOP): Neoadjuvant vepdegestrant monotherapy or in combination with letrozole or abemaciclib in molecularly selected patients with stage 2/3 HR+ ...